Project Details
Description
Over the past decade, it has become abundantly clear that cancer-initiating stem cell (CSC) elimination is imperative to ?cure? cancer. Unfortunately, most of the existing clinical therapies target the bulk tumor and spare the very small number CSCs comprising
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/16 → 9/30/17 |
Funding
- National Cancer Institute: $1,475,002.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.